Marijuana Components Show ‘Promising Potential As Anticancer Agents’, Study Finds

A new scientific review on cannabis and cancer concludes that a variety of cannabinoids—including delta-9 THC, CBD and cannabigerol (CBG)—”show promising potential as anticancer agents through various mechanisms,” for example by limiting the growth and spread of tumors. But authors acknowledged that obstacles to incorporating cannabis into cancer treatment remain, such as regulatory barriers and the need to determine optimal dosing. “Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction,…